The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global antibiotics market exhibited moderate growth during 2015-2020. Antibiotics are a group of medicines, such as penicillin, cephalosporin, fluoroquinolone, etc., that inhibit the growth of microorganisms, prevent the replication of parasites, and reduce serious complications of bacterial infections. They are generally administered orally in the form of pills, liquids, tablets, and capsules. They are also available as sprays, creams, ointments, and lotions, which are applied topically on the skin to treat certain acne and other skin diseases. Moreover, antibiotics can be administered through an injection or intravenously (IV) for severe infections according to the signs and symptoms of the patients.
The growing prevalence of infectious diseases, such as malaria, tuberculosis, pneumonia, and acquired immunodeficiency syndrome (AIDS), along with the easy availability of generic medicines, represents one of the major factors positively influencing the demand for antibiotics. Moreover, the topical application of antibiotics offers reduced potential for systemic absorption and toxicity and minimizes the risk of surgical site infections. Consequently, the rising number of surgical procedures is increasing the sales of antibiotics to prevent incision infection. They can also be utilized in the form of drops for conjunctivitis and acute ear infections. Furthermore, antibiotics are finding extensive application in livestock farming to safeguard animal health and welfare and support food safety. Apart from this, scientists are developing less reactogenic, cell-free vaccines consisting of purified components, inactivated toxins, and proteins. Additionally, several health organizations are entering into strategic partnerships with private companies to deliver new treatments and improve existing drugs. Looking forward, IMARC Group expects the global antibiotics market to grow at a CAGR of 4.5% during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the global antibiotics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, action mechanism, drug class, spectrum of activity, route of administration and end user.
Breakup by Action Mechanism:
Breakup by Drug Class:
Breakup by Spectrum of Activity:
Breakup by Route of Administration:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan Plc (AbbVie Inc.), Basilea Pharmaceutica AG, GlaxoSmithKline Plc, Johnson & Johnson, Melinta Therapeutics, Merck & Co. Inc., Nabriva Therapeutics Plc, Paratek Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Spero Therapeutics and Tetraphase Pharmaceuticals.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at